Idiopathic Unilateral Facial Hirsutism

    April 2022 in “ Our Dermatology Online ”
    Ritu Rani, Mudita Gupta, Reena Sharma, Geeta Ram Tegta
    Image of study
    TLDR A woman had unusual hair growth on one side of her chin without a known cause.
    The document reported a case of a 40-year-old female experiencing idiopathic unilateral facial hirsutism, characterized by terminal hair growth on the left side of her chin. This condition was identified as idiopathic because there was no biochemical or ultrasonic evidence of hyperandrogenism, meaning there was no increase in circulating androgens or ovarian hormones. The case was notable due to the localized and unilateral nature of the hirsutism, which had been rarely described in medical literature.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 27 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 3 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 4 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 9 months ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  106 upvotes 4 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  120 upvotes 11 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

    Related Research

    5 / 5 results